Related Experiment Video
Updated: Sep 17, 2025
07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
9.0K
Clinical cancer nanomedicines
Roger M Pallares1, Roman A Barmin1, Alec Wang1
1Institute for Experimental Molecular Imaging, RWTH Aachen University, 52074 Aachen, Germany.
Summary
Nanomedicines enhance cancer therapy by improving drug delivery, reducing toxicity, and increasing effectiveness. This review covers clinical applications, from passive delivery to advanced targeted and combination strategies for better patient outcomes.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Nanomedicines have significantly advanced cancer treatment over 30 years.
- They improve drug pharmacokinetics and biodistribution, reducing side effects.
- This leads to enhanced therapeutic indices and better patient outcomes.
Purpose of the Study:
- To review the current clinical applications of nanomedicines in cancer therapy.
- To highlight nanomedicine formulations that have achieved clinical use or are in trials.
- To identify key factors driving the successful clinical translation of nanomedicines.
Main Methods:
- Review of clinical data and literature on nanomedicine formulations for cancer.
- Analysis of conventional (passive delivery) and advanced nanomedicine strategies.
- Categorization of nanomedicines based on delivery mechanisms (stimuli-responsive, targeted, combination, immunotherapy).
Main Results:
- Several nanomedicine formulations have reached clinical approval for cancer treatment.
- Ongoing clinical trials investigate diverse nanomedicine approaches, including targeted and combination therapies.
- Advanced formulations show promise in improving immunotherapy efficacy.
Conclusions:
- Nanomedicines offer significant potential to improve cancer treatment efficacy and safety.
- Successful translation hinges on factors like targeted delivery, stimuli-responsiveness, and combination strategies.
- Continued research and development are crucial for maximizing the clinical impact of nanomedicines in oncology.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:27Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667